56 related articles for article (PubMed ID: 32776855)
1. Silencing lncRNA HOXA10-AS decreases cell proliferation of oral cancer and HOXA10-antisense RNA can serve as a novel prognostic predictor.
Yan X; Cong B; Chen Q; Liu L; Luan X; Du J; Cao M
J Int Med Res; 2020 Aug; 48(8):300060520934254. PubMed ID: 32776855
[TBL] [Abstract][Full Text] [Related]
2. Importin 7 enhances protective autophagy induced by nuclear translocation of homeobox A10 in oral squamous cell carcinoma.
Chen S; Pan J
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):241-247. PubMed ID: 38650127
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation long non-coding RNAs of oral squamous cell carcinoma by bioinformatics method.
Yang M; Xiong X; Chen L; Yang L; Li X
Oncotarget; 2017 Dec; 8(64):107469-107476. PubMed ID: 29296179
[TBL] [Abstract][Full Text] [Related]
4. OVCH1 Antisense RNA 1 is differentially expressed between non-frail and frail old adults.
Abugessaisa I; Manabe RI; Kawashima T; Tagami M; Takahashi C; Okazaki Y; Bandinelli S; Kasukawa T; Ferrucci L
Geroscience; 2024 Apr; 46(2):2063-2081. PubMed ID: 37817005
[TBL] [Abstract][Full Text] [Related]
5. Loss of Nuclear Functions of HOXA10 Is Associated With Testicular Cancer Proliferation.
Chen R; Li H; Li Y; Fazli L; Gleave M; Nappi L; Dong X
Front Oncol; 2018; 8():594. PubMed ID: 30581773
[No Abstract] [Full Text] [Related]
6. LncRNA XIST Inhibits the Progression of Oral Squamous Cell Carcinoma via Sponging miR-455-3p/BTG2 Axis.
Li Q; Sun Q; Zhu B
Onco Targets Ther; 2020; 13():11211-11220. PubMed ID: 33177835
[TBL] [Abstract][Full Text] [Related]
7. A prognostic long non-coding RNA-associated competing endogenous RNA network in head and neck squamous cell carcinoma.
Zhang C; Cao W; Wang J; Liu J; Liu J; Wu H; Li S; Zhang C
PeerJ; 2020; 8():e9701. PubMed ID: 32983633
[TBL] [Abstract][Full Text] [Related]
8. LncRNA TTN-AS1 promotes the progression of oral squamous cell carcinoma via miR-411-3p/NFAT5 axis.
Fu SW; Zhang Y; Li S; Shi ZY; Zhao J; He QL
Cancer Cell Int; 2020; 20():415. PubMed ID: 32863773
[TBL] [Abstract][Full Text] [Related]
9. Roles of the HOX Proteins in Cancer Invasion and Metastasis.
Paço A; Aparecida de Bessa Garcia S; Leitão Castro J; Costa-Pinto AR; Freitas R
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33375038
[TBL] [Abstract][Full Text] [Related]
10.
Lin J; Lian X; Xue S; Ouyang L; Zhou L; Lu Y; Xie L
Transl Cancer Res; 2023 Jan; 12(1):135-149. PubMed ID: 36760373
[TBL] [Abstract][Full Text] [Related]
11. The exploration of new biomarkers for oral cancer through the ceRNA network and immune microenvironment analysis.
Ma S; Guo J; Zhang X; Yang Y; Bao Y; Zhang S; Li T
Medicine (Baltimore); 2022 Dec; 101(49):e32249. PubMed ID: 36626444
[TBL] [Abstract][Full Text] [Related]
12. LncRNA HOXA10-AS promotes the progression of esophageal carcinoma by regulating the expression of HOXA10.
Kuai J; Wu K; Han T; Zhai W; Sun R
Cell Cycle; 2023 Feb; 22(3):276-290. PubMed ID: 36588458
[TBL] [Abstract][Full Text] [Related]
13. Circulating Long Non-Coding RNAs Could Be the Potential Prognostic Biomarker for Liquid Biopsy for the Clinical Management of Oral Squamous Cell Carcinoma.
Dey Ghosh R; Guha Majumder S
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428681
[TBL] [Abstract][Full Text] [Related]
14. Multiomics Immune-Related lncRNA Analysis of Oral Squamous Cell Carcinoma and Its Correlation with Prognosis.
Liu Z; Liu Q; Wang X; Liu L; Shi L; Li H
Dis Markers; 2022; 2022():6106503. PubMed ID: 36118668
[TBL] [Abstract][Full Text] [Related]
15. Modular scaffolding by lncRNA HOXA10-AS promotes oral cancer progression.
Chen YT; Kan CH; Liu H; Liu YH; Wu CC; Kuo YP; Chang IY; Chang KP; Yu JS; Tan BC
Cell Death Dis; 2022 Jul; 13(7):629. PubMed ID: 35858923
[TBL] [Abstract][Full Text] [Related]
16. HTR1D functions as a key target of HOXA10-AS/miR-340-3p axis to promote the malignant outcome of pancreatic cancer via PI3K-AKT signaling pathway.
Wu W; Li Q; Zhu Z; Li C; Lu P; Zhou X; Huang Y; Liu Y; Wang M; Gong J
Int J Biol Sci; 2022; 18(9):3777-3794. PubMed ID: 35813473
[TBL] [Abstract][Full Text] [Related]
17. LncRNA HOXA10-AS functions as an oncogene by binding miR-6509-5p to upregulate Y-box binding protein 1 in gastric cancer.
Li S; Lu C; Li X; Li F; Zhao Y; Xu M; Jia H; Yuan S
Bioengineered; 2022 May; 13(5):11373-11387. PubMed ID: 35521747
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Landscape of HOXA2, HOXA9, and HOXA10 as Potential Biomarkers for Predicting Progression and Prognosis in Prostate Cancer.
Song YP; Xian P; Luo H; Dai JY; Bai Y; Li Y; Tang XL
J Immunol Res; 2022; 2022():5740971. PubMed ID: 35372588
[TBL] [Abstract][Full Text] [Related]
19. +HOXA10-AS Promotes Malignant Phenotypes of Gastric Cancer via Upregulating HOXA10.
Cao F; Zheng Y; Yang C; Huang S; He X; Tong S
Comput Math Methods Med; 2022; 2022():1846687. PubMed ID: 35222681
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
